In 1998 while the world was experiencing a boom in the technology sector, Jacob Gottlieb was working in the healthcare investment sector. He was taking care of investments at Merlin where the co-founder Stuart Weisbrod has incorporated him. He was working as an investment manager for the company. Together with Weisbrod, they helped this company to make 100 percent return in one year. Merlin was later closed in 2007, and it returned all the funds to the investors. Gottlieb and Weisbrod each went separate ways. Gottlieb established Visium Asset Management while Weisbrod established Iguana Partner.
With just $300 million, Visium was set up. A decade later in 2016, it was worth $8 billion. That was such a great show by Gottlieb. He managed to do something that not many people would have managed. Together with his team, they had created a giant accompany that was competing with the big players in the industry. In the same year, something happened that brought the company to a halt, investigations were launched on the firm, and the matter led to the collapse of the company. Jacob Gottlieb who was the CIO of the firm was not implicated in anything wrong, and he was left in charge of the firm as it refunded capital to its investors.
Jacob Gottlieb is qualified as an investor in the healthcare sector, for the last two decades, he has been dealing with this industry making significant changes which can bring the industry to a position which will bear the right results. He is known as a titan in the industry due to the nature of the results that he has achieved in the past. Although the collapse of Visium was a low point in his career, he is determined to change the situation by putting up investments which will help create wealth for the investor. Jacob Gottlieb holds a degree in economics from Brown University and another one in medicine from New York University Medical School.
Currently, he is making a comeback into the industry with a new firm. He is also expected to work alongside Stuart Weisbrod. Their combination is likely to shake up the healthcare sector.